These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15913812)

  • 1. Effectiveness of low dose denopamine, a beta1-adrenoceptor agonist, in a patient with vasospastic angina refractory to intensive medical treatment.
    Nakajima D; Negoro N; Nakaboh A; Nakakoji T; Hoshiga M; Nariyama J; Ishihara T; Hanafusa T
    Int J Cardiol; 2006 Apr; 108(2):281-3. PubMed ID: 15913812
    [No Abstract]   [Full Text] [Related]  

  • 2. Multivessel coronary artery spasm refractory to intensive medical treatment.
    Asano T; Kobayashi Y; Ohno M; Nakayama T; Kuroda N; Komuro I
    Angiology; 2007; 58(5):636-9. PubMed ID: 17906282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of benidipine for vasospastic angina pectoris.
    Suzuki H; Yokoyama K; Akimoto Y; Daida H
    Arzneimittelforschung; 2007; 57(1):20-5. PubMed ID: 17341005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary Vasospasm Abutting the Stent: A Rare Though Important Cause of Recurrent Angina.
    Singh B; Goyal A; Mohan B; Chhabra ST; Aslam N; Wander GS
    J Invasive Cardiol; 2018 Jun; 30(6):E46-E47. PubMed ID: 29799427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Denopamine, a selective beta1-receptor agonist and a new coronary vasodilator.
    Ishide T
    Curr Med Res Opin; 2002; 18(7):407-13. PubMed ID: 12487507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm.
    Stone PH; Muller JE; Turi ZG; Geltman E; Jaffe AS; Braunwald E
    Arq Bras Cardiol; 1983 Dec; 41(6):469-76. PubMed ID: 6431950
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effects of long-acting nifedipine CR and diltiazem R in patients with vasospastic angina: Aomori coronary spastic angina study.
    Higuma T; Oikawa K; Kato T; Mori Y; Kudo T; Yamamoto T; Hoshi Y; Kameda K; Suto N; Fujita N; Inokubo Y; Konta A; Osanai T; Okumura K
    J Cardiol; 2010 Nov; 56(3):354-60. PubMed ID: 20884177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angina pectoris presenting with unusual form of coronary spasm: a case report].
    Noike H; Satoh S; Kawana H; Hirano K; Sakurai T; Sugiyama Y; Iizuka T; Takahashi M; Shimizu K; Nakamura K; Ohsawa H; Kawashima T
    J Cardiol; 2006 Feb; 47(2):85-9. PubMed ID: 16515358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lidoflazine in angina pectoris].
    Schlesinger P; Benchimol AB
    Arq Bras Cardiol; 1972 Oct; 25(5):397-403. PubMed ID: 4651962
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association.
    Takahashi J; Nihei T; Takagi Y; Miyata S; Odaka Y; Tsunoda R; Seki A; Sumiyoshi T; Matsui M; Goto T; Tanabe Y; Sueda S; Momomura S; Yasuda S; Ogawa H; Shimokawa H;
    Eur Heart J; 2015 Jan; 36(4):228-37. PubMed ID: 25189599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molsidomine in the long-term treatment of angina pectoris].
    Blasini R; Brügmann U; Mannes A; Rudolph W
    Herz; 1982 Oct; 7(5):307-16. PubMed ID: 6818116
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of a new anti-angina drug: Vascoril (67 53 MD)].
    Warembourg H; Bertrand M; Ginestet A
    Lille Med; 1972 May; 17():Suppl 4:804-8. PubMed ID: 5056283
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with a new coronary-active substance (BAY 1 1040).
    Kobayashi T; Ito Y; Tawara I
    Arzneimittelforschung; 1972 Feb; 22(2):380-9. PubMed ID: 5067492
    [No Abstract]   [Full Text] [Related]  

  • 14. Sudden ST elevation with angina-like pain in myocarditis. An uncommon course of a common disease: strategic role of cardiac magnetic resonance.
    Gibelli G; Devizzi S; Brioschi P; Rimini A; Biasi S
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):264-6. PubMed ID: 19262213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthyroidism-associated coronary vasospasm with myocardial infarction and subsequent euthyroid angina.
    Patel R; Peterson G; Rohatgi A; Ghayee HK; Keeley EC; Auchus RJ; Chang AY
    Thyroid; 2008 Feb; 18(2):273-6. PubMed ID: 18279027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies on the action of iproveratril in coronary insufficiency and on the influencing of myocardial function using sympatholytics].
    Hofmann H
    Z Gesamte Inn Med; 1968 Jun; 23(12):357-64. PubMed ID: 4386847
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of refractory vasospastic angina with corticosteroids: coronary arterial hyperactivity caused by local inflammation?
    Takagi S; Goto Y; Hirose E; Terashima M; Sakuragi S; Suzuki S; Tsutsumi Y; Miyazaki S; Nonogi H
    Circ J; 2004 Jan; 68(1):17-22. PubMed ID: 14695460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of vasospastic angina].
    Delcán Domińguez JL; Abeytua Jimeńez M
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II43-51. PubMed ID: 7170407
    [No Abstract]   [Full Text] [Related]  

  • 19. Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study.
    IONA Study Group
    Am Heart J; 2005 Oct; 150(4):689. PubMed ID: 16209965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of denopamine, a beta 1 adrenoceptor agonist, in preventing coronary artery spasm.
    Shimizu H; Lee JD; Ogawa KB; Shimizu K; Yamamoto M; Hara A; Nakamura T
    Jpn Circ J; 1993 Mar; 57(3):175-82. PubMed ID: 8096549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.